Complex treatment of non-alcoholic fatty liver disease: experience of the use of hepatoprotectors
Journal Title: Сучасна гастроентерологія - Year 2018, Vol 0, Issue 2
Abstract
Objective — to evaluate the complex therapy effects at the levels of cytokeratin (CK)-18, fibroblast growth factor (FGF)-21 and metabolic parameters of nonalcoholic fatty liver disease (NAFLD) patients. Materials and methods. examinations involved 90 patients with NAFLD, aged 30 to 60 years (the men age (48.61 ± 4.1) years). The control group consisted of 20 practically healthy volunteers. Gender difference between groups wasn’t significant. Levels of SC-18 and FGF-21 with the use immune enzyme method with ELISA kits were performed at baseline and 1 months after the beginning of treatment with combination of ursodeoxycholic acid and ademetionine, Results. Before the treatment, NAFLD patients demonstrated the increased liver enzymatic activity (р ≤ 0.05); lipid profile indices (p ≤ 0.05); the increased levels of insulin and HOMAIR (p = 0.002), and plasma levels of cytokines CK-18 and FGF-21 (p ≤ 0.05). After 1 months of treatment, the following positive effects were revealed: reduction of ALT and AST levels (p ≤ 0.05), decrease of glucose levels by 10.5 %, HOMA index by 41 % (p = 0.001), level of total cholesterol decreased from 5.6 to 4.89 mmol/L, triglycerides’ levels from 1.7 to 1.24 mmol/L (p = 0.001). Conclusions. The combined therapy of ademetionine and ursodeoxycholic acid in patients with NAFLD promoted the reduction of the transaminases’, glucose levels and HOMAindex, resulted in the eliminating of hyperlipidemia and hypertriglyceridemia, as well as reducing of apoptotic processes in the liver.
Authors and Affiliations
O. Ya. Babak, K. A. Lapshyna, А. M. Chernyak
Keywords
Related Articles
- EP ID EP295148
- DOI -
- Views 126
- Downloads 0
The role of serum biomarkers in the diagnosis of nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is a disease characterized by liver steatosis and the ability to progress to more serious pathological conditions, including non-alcoholic steatohepatitis (NASH), fibrosis and ci...
Functional dyspepsia: diagnostic and therapeutic options
Objective — to study the effects of digestive enzymes on the symptoms of functional dyspepsia FD and the state of gastric motility. Materials and methods. Observations involved 60 patients with FD (21 men and 39 women,...
Gastrointestinal involvement in systemic sclerosis: diagnostic and therapeutic aspects
Systemic sclerosis (SSc) is a rare autoimmune disorder that carries a high morbidity and mortality. It is characterized by fibrosis of multiple organs including skin, musculoskeletal system, the lungs, kidneys, heart and...
The interrelation between disorders of intestinal microbiocenosis and level of serum serotonin in patients with diabetic enteropathy
Objective — to investigate the interrelation between disorders of intestinal microbiocenosis and the level of serum serotonin in patients with type 2diabetes mellitus (DM 2). Materials and methods. The investigation has...
United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis
-